CN Patent

CN117881786A — 表达治疗性抗体的非病毒dna载体及其用途

Assigned to Generational Biology Co · Expires 2024-04-12 · 2y expired

What this patent protects

本申请描述了包含可用于在细胞、组织或受试者中表达抗体及其抗原结合片段的ceDNA载体的方法和组合物，以及治疗和/或预防各种疾病、病症和癌症的方法。

USPTO Abstract

本申请描述了包含可用于在细胞、组织或受试者中表达抗体及其抗原结合片段的ceDNA载体的方法和组合物，以及治疗和/或预防各种疾病、病症和癌症的方法。

Drugs covered by this patent

vutrisiran-sodium (VUTRISIRAN SODIUM)

Patent Metadata

Patent number: CN117881786A
Jurisdiction: CN
Classification: —
Expires: 2024-04-12
Drug substance claim: No
Drug product claim: No
Assignee: Generational Biology Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.